Trial Profile

Open Label, Prospective, Exploratory Study to Investigate the Effect of Inhaled CHF5993 pMDI on Central and Peripheral Airway Dimensions in COPD Patients by Functional Respiratory Imaging

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 05 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

21 Oct 2020 Primary endpoint (Specific image-based airway resistance (siRaw)) has been met, as per Results presented at the CHEST Annual Meeting 2020 by Annual Meeting of the American College of Chest Physicians
21 Oct 2020 Primary endpoint (Specific image-based airway volumes (siVaw)) has been met, as per Results presented at the CHEST Annual Meeting 2020 by Annual Meeting of the American College of Chest Physicians
21 Oct 2020 Results presented at the CHEST Annual Meeting 2020 by Annual Meeting of the American College of Chest Physicians

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com